Eintrag weiter verarbeiten
| author_facet |
Arepally, Gowthami M. Ortel, Thomas L. Arepally, Gowthami M. Ortel, Thomas L. |
|---|---|
| author |
Arepally, Gowthami M. Ortel, Thomas L. |
| spellingShingle |
Arepally, Gowthami M. Ortel, Thomas L. Blood Bad weed: synthetic cannabinoid–associated coagulopathy Cell Biology Hematology Immunology Biochemistry |
| author_sort |
arepally, gowthami m. |
| spelling |
Arepally, Gowthami M. Ortel, Thomas L. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2018-11-876839 <jats:title>Abstract</jats:title> <jats:p>Recent multistate outbreaks of coagulopathy caused by brodifacoum-tainted synthetic cannabinoids or “fake weed” highlight the public health impact of long-acting anticoagulant rodenticides (LAARs). Patients presenting with this syndrome have had recent exposure to synthetic cannabinoids, evidence of isolated vitamin K antagonism with or without bleeding, and detectable levels of brodifacoum and other LAARs in circulation. This article will provide information on synthetic cannabinoids, LAARs, and coagulopathic manifestations arising from use of adulterated synthetic cannabinoids and their management.</jats:p> Bad weed: synthetic cannabinoid–associated coagulopathy Blood |
| doi_str_mv |
10.1182/blood-2018-11-876839 |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie Biologie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE4LTExLTg3NjgzOQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE4LTExLTg3NjgzOQ |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
American Society of Hematology, 2019 |
| imprint_str_mv |
American Society of Hematology, 2019 |
| issn |
0006-4971 1528-0020 |
| issn_str_mv |
0006-4971 1528-0020 |
| language |
English |
| mega_collection |
American Society of Hematology (CrossRef) |
| match_str |
arepally2019badweedsyntheticcannabinoidassociatedcoagulopathy |
| publishDateSort |
2019 |
| publisher |
American Society of Hematology |
| recordtype |
ai |
| record_format |
ai |
| series |
Blood |
| source_id |
49 |
| title |
Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_unstemmed |
Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_full |
Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_fullStr |
Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_full_unstemmed |
Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_short |
Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_sort |
bad weed: synthetic cannabinoid–associated coagulopathy |
| topic |
Cell Biology Hematology Immunology Biochemistry |
| url |
http://dx.doi.org/10.1182/blood-2018-11-876839 |
| publishDate |
2019 |
| physical |
902-905 |
| description |
<jats:title>Abstract</jats:title>
<jats:p>Recent multistate outbreaks of coagulopathy caused by brodifacoum-tainted synthetic cannabinoids or “fake weed” highlight the public health impact of long-acting anticoagulant rodenticides (LAARs). Patients presenting with this syndrome have had recent exposure to synthetic cannabinoids, evidence of isolated vitamin K antagonism with or without bleeding, and detectable levels of brodifacoum and other LAARs in circulation. This article will provide information on synthetic cannabinoids, LAARs, and coagulopathic manifestations arising from use of adulterated synthetic cannabinoids and their management.</jats:p> |
| container_issue |
9 |
| container_start_page |
902 |
| container_title |
Blood |
| container_volume |
133 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792341274156597252 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:17:08.423Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Bad+weed%3A+synthetic+cannabinoid%E2%80%93associated+coagulopathy&rft.date=2019-02-28&genre=article&issn=1528-0020&volume=133&issue=9&spage=902&epage=905&pages=902-905&jtitle=Blood&atitle=Bad+weed%3A+synthetic+cannabinoid%E2%80%93associated+coagulopathy&aulast=Ortel&aufirst=Thomas+L.&rft_id=info%3Adoi%2F10.1182%2Fblood-2018-11-876839&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792341274156597252 |
| author | Arepally, Gowthami M., Ortel, Thomas L. |
| author_facet | Arepally, Gowthami M., Ortel, Thomas L., Arepally, Gowthami M., Ortel, Thomas L. |
| author_sort | arepally, gowthami m. |
| container_issue | 9 |
| container_start_page | 902 |
| container_title | Blood |
| container_volume | 133 |
| description | <jats:title>Abstract</jats:title> <jats:p>Recent multistate outbreaks of coagulopathy caused by brodifacoum-tainted synthetic cannabinoids or “fake weed” highlight the public health impact of long-acting anticoagulant rodenticides (LAARs). Patients presenting with this syndrome have had recent exposure to synthetic cannabinoids, evidence of isolated vitamin K antagonism with or without bleeding, and detectable levels of brodifacoum and other LAARs in circulation. This article will provide information on synthetic cannabinoids, LAARs, and coagulopathic manifestations arising from use of adulterated synthetic cannabinoids and their management.</jats:p> |
| doi_str_mv | 10.1182/blood-2018-11-876839 |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie, Biologie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE4LTExLTg3NjgzOQ |
| imprint | American Society of Hematology, 2019 |
| imprint_str_mv | American Society of Hematology, 2019 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0006-4971, 1528-0020 |
| issn_str_mv | 0006-4971, 1528-0020 |
| language | English |
| last_indexed | 2024-03-01T16:17:08.423Z |
| match_str | arepally2019badweedsyntheticcannabinoidassociatedcoagulopathy |
| mega_collection | American Society of Hematology (CrossRef) |
| physical | 902-905 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | American Society of Hematology |
| record_format | ai |
| recordtype | ai |
| series | Blood |
| source_id | 49 |
| spelling | Arepally, Gowthami M. Ortel, Thomas L. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2018-11-876839 <jats:title>Abstract</jats:title> <jats:p>Recent multistate outbreaks of coagulopathy caused by brodifacoum-tainted synthetic cannabinoids or “fake weed” highlight the public health impact of long-acting anticoagulant rodenticides (LAARs). Patients presenting with this syndrome have had recent exposure to synthetic cannabinoids, evidence of isolated vitamin K antagonism with or without bleeding, and detectable levels of brodifacoum and other LAARs in circulation. This article will provide information on synthetic cannabinoids, LAARs, and coagulopathic manifestations arising from use of adulterated synthetic cannabinoids and their management.</jats:p> Bad weed: synthetic cannabinoid–associated coagulopathy Blood |
| spellingShingle | Arepally, Gowthami M., Ortel, Thomas L., Blood, Bad weed: synthetic cannabinoid–associated coagulopathy, Cell Biology, Hematology, Immunology, Biochemistry |
| title | Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_full | Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_fullStr | Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_full_unstemmed | Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_short | Bad weed: synthetic cannabinoid–associated coagulopathy |
| title_sort | bad weed: synthetic cannabinoid–associated coagulopathy |
| title_unstemmed | Bad weed: synthetic cannabinoid–associated coagulopathy |
| topic | Cell Biology, Hematology, Immunology, Biochemistry |
| url | http://dx.doi.org/10.1182/blood-2018-11-876839 |